Cardiometabolic News and Research

RSS

Study reveals low utilization of PCSK9 inhibitors in high-risk patients

A new study published in Circulation: Cardiovascular Quality and Outcomes from the Family Heart Foundation -; a patient-centered research and advocacy nonprofit organization dedicated to improving the lives of families impacted by inherited lipid disorders and LDL-cholesterol -; revealed that utilization of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) to reduce low-density lipoprotein cholesterol (LDL-C) remains low among high-risk patients.

20 Feb 2024

Are avocados good for your heart health?

The effects of avocado intake on cardiometabolic risk factors.

20 Feb 2024

Melatonin treatment does not affect insulin resistance of night shift workers

Melatonin treatment does not affect the insulin resistance or the glucose tolerance of night shift workers, according to a new study from the University of Surrey and the University Medical Centre Hamburg.

19 Feb 2024

Study highlights the need for urgent action on child hunger and malnutrition

Urgent action is needed to address the millions of children suffering from hunger and malnutrition worldwide, according to the authors of a study which tracked the health of children over 15 years.

16 Feb 2024

Black cumin: Ancient superseed with modern health benefits

Review discusses the multifaceted role of Nigella sativa in treating cardiometabolic diseases, highlighting its bioactive components like thymoquinone, which contribute to its antioxidant, anti-inflammatory, and anti-dyslipidemic properties.

13 Feb 2024

Proteomic biomarkers in blood plasma as predictors of dementia in healthy individuals

The predictive power of plasma proteomic profiles for future dementia onset in adults without dementia.

13 Feb 2024

Blueberries boost calmness but not cognition in metabolic syndrome study

A study in the American Journal of Clinical Nutrition finds that chronic blueberry intake does not significantly improve cognitive function, alertness, or mood in adults with metabolic syndrome, despite a slight improvement in picture recognition accuracy and self-rated calmness after a high-fat, high-sugar meal.

12 Feb 2024

Prenatal exposure to phthalates linked to higher risk of preterm birth and low birth weight

Research in The Lancet Planetary Health links prenatal phthalate exposure to increased risks of preterm birth and low birth weight, underscoring the need for regulatory oversight on chemicals used in consumer products.

11 Feb 2024

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to develop a portable rapid polymerase chain reaction (PCR) diagnostic to detect the presence of the pathogen that causes gonorrhea, Neisseria gonorrhoeae (NG), and its susceptibility to ciprofloxacin, a former frontline oral antibiotic that can no longer treat resistant NG.

9 Feb 2024

Snacking on pistachios may combat metabolic syndrome risk without weight gain

More than half of Americans do not currently meet the daily recommendation of 5–7 ounce equivalents of nuts and seeds per week.

7 Feb 2024

Eleven stroke researchers to be recognized during the 2024 International Stroke Conference

Eleven scientists leading the way in stroke research will be recognized during the American Stroke Association's International Stroke Conference 2024 for their exceptional professional achievements.

6 Feb 2024

Bariatric surgery more effective in controlling hypertension rates in obese patients

Bariatric surgery is more effective in controlling hypertension rates, or high blood pressure, in people with obesity and uncontrolled high blood pressure compared to blood pressure medication alone, according to a study published today in the Journal of the American College of Cardiology.

6 Feb 2024

New weight loss drug may be an effective strategy for preventing or treating high blood pressure

The new weight loss medication tirzepatide significantly lowered the systolic blood pressure (the top number in a blood pressure reading) for nearly 500 adults with obesity who took the medication for about eight months, according to new research published today in Hypertension, an American Heart Association journal.

5 Feb 2024